Kirsten Sundby Hall

  • 2849 Citations
  • 24 h-Index
1986 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 2 Similar Profiles
Sarcoma Medicine & Life Sciences
Osteosarcoma Medicine & Life Sciences
Gastrointestinal Stromal Tumors Medicine & Life Sciences
Survival Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Ewing's Sarcoma Medicine & Life Sciences
Recurrence Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1986 2019

Sarcoma
Epidemiology
Bone and Bones
Population
Survival
8 Citations

Activity of Pazopanib and Trabectedin in Advanced Alveolar Soft Part Sarcoma

Stacchiotti, S., Mir, O., Le Cesne, A., Vincenzi, B., Fedenko, A., Maki, R. G., Somaiah, N., Patel, S., Brahmi, M., Blay, J. Y., Boye, K., Hall, K. S., Gelderblom, H., Hindi, N., Martin-Broto, J., Kosela, H., Rutkowski, P., Italiano, A., Duffaud, F., Kobayashi, E. & 3 othersCasali, P. G., Provenzano, S. & Kawai, A., Jan 1 2018, In : Oncologist. 23, 1, p. 62-70 9 p.

Research output: Contribution to journalArticle

trabectedin
Alveolar Soft Part Sarcoma
Sarcoma
Disease-Free Survival
Rare Diseases
4 Citations

Adjuvant chemotherapy and postoperative radiotherapy in high-risk soft tissue sarcoma patients defined by biological risk factors—A Scandinavian Sarcoma Group study (SSG XX)

Hall, K. S., Bruland, O., Bjerkehagen, B., Zaikova, O., Engellau, J., Hagberg, O., Hansson, L., Hagberg, H., Ahlström, M., Knobel, H., Papworth, K., Zemmler, M., Goplen, D., Bauer, H. C. F. & Eriksson, M., Aug 1 2018, In : European Journal of Cancer. 99, p. 78-85 8 p.

Research output: Contribution to journalArticle

Biological Factors
Adjuvant Chemotherapy
Sarcoma
Radiotherapy
Survival
5 Citations

EURO-B.O.S.S. A European study on chemotherapy in bone-sarcoma patients aged over 40: Outcome in primary high-grade osteosarcoma

Ferrari, S., Bielack, S. S., Smeland, S., Longhi, A., Egerer, G., Hall, K. S., Donati, D., Kevric, M., Brosjö, O., Comandone, A., Werner, M., Monge, O., Palmerini, E., Berdel, W. E., Bjerkehagen, B., Paioli, A., Lorenzen, S., Eriksson, M., Gambarotti, M., Tunn, P. U. & 13 othersJebsen, N. L., Cesari, M., von Kalle, T., Ferraresi, V., Schwarz, R., Bertulli, R., Kasparek, A. K., Grignani, G., Krasniqi, F., Sorg, B., Hecker-Nolting, S., Picci, P. & Reichardt, P., Jan 1 2018, In : Tumori. 104, 1, p. 30-36 7 p.

Research output: Contribution to journalArticle

Osteosarcoma
Sarcoma
Bone and Bones
Drug Therapy
Methotrexate

Expression of cell cycle regulators and frequency of TP53 mutations in high risk gastrointestinal stromal tumors prior to adjuvant imatinib treatment

Ihle, M. A., Huss, S., Jeske, W., Hartmann, W., Merkelbach-Bruse, S., Schildhaus, H. U., Büttner, R., Sihto, H., Hall, K. S., Eriksson, M., Reichardt, P., Joensuu, H. & Wardelmann, E., Feb 1 2018, In : PloS one. 13, 2, e0193048.

Research output: Contribution to journalArticle

Gastrointestinal Stromal Tumors
Mutation Rate
adjuvants
Tumors
cell cycle